MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
7.00
-0.07
-0.99%
After Hours: 7.10 +0.1 +1.43% 19:46 04/02 EDT
OPEN
6.84
PREV CLOSE
7.07
HIGH
7.00
LOW
6.76
VOLUME
920.01K
TURNOVER
--
52 WEEK HIGH
9.94
52 WEEK LOW
3.809
MARKET CAP
413.76M
P/E (TTM)
-1.8710
1D
5D
1M
3M
1Y
5Y
1D
Vanda Announces Resignation of Senior Legal Executive
TipRanks · 10h ago
Vanda SVP, General Counsel Timothy Williams resigns effective April 10
Reuters · 11h ago
Analysts Offer Insights on Healthcare Companies: Lucid Diagnostics (LUCD), Vanda (VNDA) and Cytokinetics (CYTK)
TipRanks · 3d ago
Weekly Report: what happened at VNDA last week (0323-0327)?
Weekly Report · 3d ago
Weekly Report: what happened at VNDA last week (0316-0320)?
Weekly Report · 03/23 09:14
Vanda Pharmaceuticals Advocates For Stronger FDA Measures To Accelerate Shift From Animal Testing To Human-Relevant Methods
Benzinga · 03/19 20:39
Vanda Pharmaceuticals urges FDA to revise draft guidance on non-animal testing methods
Reuters · 03/19 20:35
EMA: ISSUED ITS OPINION ON HETLIOZ MARKETING AUTHORISATION CHANGE AFTER RE-EXAMINATION ON 16 MARCH
Reuters · 03/17 16:16
More
About VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.